SANTA CLARA, Calif., Aug. 12 /PRNewswire-FirstCall/ —
NewCardio, Inc., (OTC Bulletin Board: http://www.newcardio.com.
Select questions for the conference call will also be taken via
email at
nwci@haydenir.com and can be sent any time prior to the
conference call’s starting time. A replay of the call will be
available by dialing 1-877-870-5176 (domestic) or 1-858-384-5517
(international) and referencing passcode 4339629.
About NewCardio, Inc.
NewCardio is a
cardiac diagnostic and services company developing and marketing
proprietary
software platform technologies to provide higher accuracy to,
and increase the value of, the standard 12-lead ECG.
NewCardio’s 3D ECG software platform reduces the time and
expense involved in assessing cardiac status while increasing the
ability to diagnose clinically significant conditions which were
previously difficult to detect. NewCardio’s software products
and services significantly improve the diagnosis and monitoring of
cardiovascular disease, as well as cardiac safety assessment of
drugs under development. For more information, visit www.newcardio.com.
Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements include, but are not limited to,
statements that express our intentions, beliefs, expectations,
strategies, predictions or any other statements relating to our
future activities or other future events or conditions. These
statements are based on current expectations, estimates and
projections about our business based on currently available
information and assumptions made by management. Although we believe
that the assumptions on which the forward-looking statements
containe
‘/>”/>
